Sec Form 3 Filing - Sire Group Ltd. @ TITAN PHARMACEUTICALS INC - 2023-09-13

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Sire Group Ltd. 2. Issuer Name and Ticker or Trading Symbol TITAN PHARMACEUTICALS INC [ TTNP] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) NO. 4, FRANKY BUILDING,, PROVIDENCE INDUSTRIAL ESTATE 3. Date of Earliest Transaction (MM/DD/YY) 09/13/2023 (Street) MAHE, T200000 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 20,836,266 ( 1 ) D ( 2 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Series AA Convertible Preferred Stock ("Preferred Stock") $ 0.466 09/13/2023 ( 3 ) Common Stock 20,836,266 ( 1 ) D ( 2 )

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Sire Group Ltd. NO. 4, FRANKY BUILDING, PROVIDENCE INDUSTRIAL ESTATE MAHE, T200000 X Shen Seow Gim NO. 4, FRANKY BUILDING, PROVIDENCE INDUSTRIAL ESTATE MAHE, T200000 X Signatures THE SIRE GROUP LTD, By: /s/ Seow Gim Shen, Chief Executive Officer 10/04/2023 Signature of Reporting Person Date /s/ Seow Gim Shen 10/04/2023 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The total number of shares into which the Preferred Stock ultimately is convertible is as set forth in the table, but the Preferred Stock contains restrictions limiting the number of converted shares that the reporting persons may have at any one time, without Issuer stockholder approval, to 3,001,757 shares. ( 2 )Seow Gim Shen owns the shares beneficial ownership is indirect, by virtue of his sole ownership of The Sire Group Ltd., which owns the shares directly. ( 3 )Not Applicable

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.